PRN: Elsevier Appoints New Managing Director for Global Clinical Reference Group
Elsevier Appoints New Managing Director for Global Clinical Reference Group
PHILADELPHIA, Pennsylvania, April 25, 2012 /PRNewswire/ --
Jim Donohue to lead development of ClinicalKey, world's first clinical insight engine
Elsevier, a world-leading provider of scientific, technical and medical information products and services, has appointed Jim Donohue as Managing Director of the Global Clinical Reference group in Elsevier Health Sciences. In this new role, Donohue will report to Michael Hansen, CEO of Elsevier Health Sciences.
One of Donohue's first responsibilities is the commercial launch in April 2012 of Elsevier's ClinicalKey, the world's first clinical insight engine. ClinicalKey provides relevant, fast, trusted and comprehensive clinical answers for clinicians.
"Jim brings much experience and valuable knowledge to his new role at Elsevier Health Science," said Michael Hansen, CEO of Elsevier Health Sciences. "Healthcare is increasingly content and data-driven, and we are continuously looking for new and better ways to put our world-leading medical reference content into the hands of clinicians around the globe. Jim and his team will be spearheading those efforts."
Jim Donohue started at Elsevier in 2006 as Managing Director for Science & Technology books and then worked as the SVP/General Manager of MD Consult. Prior to Elsevier, Donohue served as the Senior Vice President of Sales and Marketing for Augsburg Fortress, and prior to that he founded and served as CEO of NetDoctor, the U.K.'s leading internet health website and one of the fifth most visible websites in the U.K. at the time. Donohue has also held vice president positions for EMEA at Times Mirror International Publishers, and was vice president for marketing at Harper Collins.
Jim is based in Philadelphia. He has a B.A. in Political Science and Rhetoric from the University of Arizona and an M.A. in Rhetoric and Public Address from the University of Iowa.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, includingÂ The LancetÂ andCell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions includeÂ SciVerse ScienceDirect,Â SciVerse Scopus,Â Reaxys,Â MD ConsultÂ andÂ Mosby's Nursing Suite, which enhance the productivity of science and health professionals, and theÂ SciVal suiteÂ andÂ MEDai's Pinpoint Review, which help researc! h and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered inÂ Amsterdam,Â ElsevierÂ employs 7,000 people worldwide. The company is part ofÂ Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Company Codes: LSE:REL, NYSE:RUK, NYSE:ENL